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Abstract 
Background: Biomarkers of Major Depressive Disorder(MDD), its phases and forms have long 
been sought. Research indicates that the complexity measures of the cortical electrical activity 
(EEG) might be candidates for this role.   
Aims: To examine whether the complexity of EEG activity, measured by Higuchi’s fractal 
dimension (HFD) and sample entropy (SampEn), differs between healthy subjects, patients in 
remission and episode phase of the recurrent depression and whether the changes are 
differentially distributed between hemispheres and cortical regions.  
Methods: Resting state EEG with eyes closed was recorded from 26 patients suffering from 
recurrent depression and 20 age and sex-matched healthy control subjects. Artefact-free EEG 
epochs were analyzed by in-house developed programs running HFD and SampEn algorithms.  
Results: Depressed patients had higher HFD and SampEn complexity compared to healthy 
subjects. Surprisingly, the complexity was even higher in patients who were in remission than in 
those in the episode. Altered complexity was present in the frontal and centro-parietal regions 
when compared to control group. The complexity in frontal and parietal regions differed between 
the two phases of depressive disorder. SampEn manifested higher sensitivity than HFD in some 
cortical areas.  
Conclusions: Complexity measures of EEG distinguish between the three groups. Further studies 
are needed to establish whether these measures carry a potential to aid clinically relevant 
decisions about depression.  
 
Keywords: Electroencephalogram, Higuchi’s fractal dimension, sample entropy, 
complexity, recurrent depression, episode, remission 
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Introduction 
Major Depressive Disorder (MDD) is a serious mental illness associated with protracted 
personal suffering, and significant social and functional impairment. It has become the leading 
cause of ill health and disability worldwide, before heart diseases, arthritis and many forms of 
cancer. Depression has a strong tendency to reoccur - a significant number of patients will suffer 
from at least one more episode after the first one, reaching four episodes on average during the 
lifetime [1]. In these patients, the risk of new episodes rises significantly with each subsequent 
recurrence although the course of the disease can be unique [1]. Hence, the decision to stop the 
therapy, or to initiate the maintenance therapy to prevent a relapse in patients with recurrent 
depression who have achieved remission, often presents a significant clinical challenge [2]. 
Therefore, finding accurate and reliable biomarkers that can help differentiate MDD episode 
from remission is of considerable importance. Also, there is a need to distinguish the (onset) 
episode of bipolar disorder from a depressive episode in Major Depression [3] in order to treat it 
appropriately. 
Stress hormones, most of all cortisol, have long been the main candidate biomarkers for 
depression, but the results of numerous studies are inconclusive [4]. It seems that combined 
biomarkers are more promising than any single one [5], but there still are no biomarkers that are 
sufficiently sensitive and specific [6]. 
Methods based on the theory of nonlinear dynamics are justly included in the quest for 
biomarkers. They provide more accurate information than classical spectral analysis and have 
already enabled insights into neural activity and connectivity in both healthy physiological 
processes and pathological conditions. The first study that used nonlinear measures in depression 
showed that EEG dynamics, measured by correlation dimension, in patients with Major 
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Depressive Disorder (MDD) is more predictable, i.e., less complex than in healthy subjects [7]. 
Contrary to this result, Lempel–Ziv complexity measure of the EEG signal is higher in depressed 
patients compared to control subjects, particularly in anterior brain regions [8]. Furthermore, 
patients suffering multiple depressive episodes do not recover dynamics found in healthy 
subjects as patients who had one depressive episode [9]. The analysis of EEG signal with 
Approximate Entropy also showed higher values in normal controls compared to depression 
patients [10]. Other studies utilizing Lempel-Ziv complexity and other complexity measures 
found either no difference between MDD and control subjects [11], or increased EEG 
complexity in patients with depression [8,11–13]. Analyses of EEG complexity with Higuchi’s 
fractal dimension (HFD) also showed increased EEG complexity in patients with depression, 
particularly in the beta and gamma sub-bands mostly in the frontal area [11,12]. Application of 
wavelet-chaos methodology found significantly increased complexity in both parietal and frontal 
regions in MDD patients, both in full-band activity and in beta and gamma EEG sub-bands [13]. 
De la Torre-Lugue and Xavier Bornas [14] in their review study concluded that ‘EEG dynamics 
for depressive patients appear more complex but may be more random than the dynamics of 
healthy non-depressed individuals’.  
In this study, we explore the use of different measures of complexity of brain activity, 
estimated from the resting state electroencephalogram (EEG) records, in discriminating episode 
from remission phase in patients with recurrent depression, as well as from healthy subjects.   
Methods 
Subjects 
EEG data were recorded at the Institute for Mental Health in Belgrade, Serbia. The 
participants were 26 patients (17 women and 9 men) suffering from recurrent depression, 25 to 
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68 years old (mean 32.40, SD 10.16). As a control, we used EEG recordings of 20 age-matched 
(mean 30.14, SD 8.94) healthy controls (10 males, 10 females) with no history of any 
neurological or psychiatric disorders, recorded at the Institute for Experimental Phonetic and 
Speech Pathology in Belgrade, Serbia. All participants were right-handed, according to 
Edinburgh Handedness Inventory. The participants were informed about the experimental 
protocol and signed informed consent. The protocol was approved by the Ethical Committees of 
the participating institutions. All participants with depression were on medications and under the 
supervision of an experienced specialist in clinical psychiatry. Their diagnoses was made 
according to ICD-10 scale. The study compared three groups: healthy controls (C), and 
depressed patients (D) in an episode (E), and in remission (R).   
Data acquisition 
EEG was recorded in the resting state with 10/20 International system for electrode 
placement, using NicoletOne Digital EEG Amplifier (VIAYSYS Healthcare Inc. NeuroCare 
Group), with closed eyes without any stimulus (resting state EEG). EEGs were recorded from 19 
electrodes in a monopolar montage (Electro-cap International Inc. Eaton, OH USA). The 
sampling rate was 1 kHz. The resistance was kept less than five KOhm. A bandpass filter was 
0.5-70 Hz. The same setup was used for the control group, using Nihon Kohden Inc. apparatus. 
Since the protocol of recordings was the same, the fact that we used recordings from two 
different EEG producers’ apparata did not introduce the difference between the groups [15].  
Each recording lasted for three minutes. Participants were instructed to reduce any 
movement, staying in a comfortable sitting position with eyes closed. The EEG records of four 
subjects were discarded from further analyses because of the high level of muscle activity or 
blinking artifacts. Further, we used records from 22 patients and 20 healthy controls for this 
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study. Half of the patients were recorded while they were in an acute episode, while the other 
half were in remission phase of the disease. Artifacts were carefully inspected and removed 
manually from the records by two independent experts. From each artifact-free record, we chose 
three epochs: one from the beginning, one from the middle and the last one close to the end of 
the record. Each epoch comprises of 5000 samples. Positions of epochs in each person’s EEG 
recording were specified by the ordinal number of the first sample in that epoch. Therefore, for 
each subject, epoch, and electrode, two nonlinear measures were calculated. 
Data analysis 
Initially, the classical spectral analysis was performed by constructing spectral power 
maps (EEGLAB program [16]). Thereon, for all EEG epochs, Higuchi’s fractal dimension 
(HFD) and Sample entropy (SampEn) were calculated. Fractal and SampEn maps were 
constructed on the whole spectrum, not dividing the signal into bands. The analysis was adopted 
as it has been shown that the Fourier analysis is redundant to fractal analyses [17]. The fractal 
dimension of EEG was calculated by using Higuchi’s algorithm [18], demonstrated to be the 
most appropriate for electrophysiological data [19]. This method provides a reasonable estimate 
of the fractal dimension even if short signal segments are analyzed and it is computationally fast. 
HFD was also chosen because it is widespread in the EEG literature facilitating comparison of 
the results. We performed the Higuchi's algorithm [18], with the maximal length of an 
epoch  kmax= 8, shown to perform the best for this type of signals [20]. HFD of a time series is a 
measure of its complexity and self-similarity in the time domain. HFD is not an integer, and the 
value of fractal dimension (FD) of waveforms (e.g. EEG) can range between 1 and 2. Higher 
self-similarity and complexity results in higher HFD [21]. Sample Entropy (SampEn) was 
computed according to the procedure by Richman and Moorman [22]. SampEn estimates the 
signal complexity by computing the conditional probability that two sequences of a given 
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length n, similar for m points, remain similar within tolerance r at the next data point (when self-
matches are not included). SampEn measures the irregularity of the data (the higher the values, 
the less regular signal) that is related to signal complexity [23]. SampEn was calculated using 
tolerance level of r = 0.15 times the standard deviation of the time series and m = 2, shown to be 
optimal for EEG [24]. Both HFD and SampEn were calculated for each electrode for the duration 
of signal (the epochs of artifact-free recorded EEG; three epochs from each recording), using the 
in-house written algorithm in Java programming language. It should also be noted that 
correlations with any medical data were not explored since the main aim of the study was to find 
independent nonlinear markers based on analysis of the EEG signal, which could be utilized as 
an additional tool in clinical practice.  
Statistical analysis 
Both HFD and SampEn values were used as an ensemble for analysis of variance 
(ANOVA with post-hoc Bonferroni correction, SPSS Statistics version 20.0, SPSS Inc, USA). 
The Kolmogorov Smirnov test showed that HFD and SampEn data were not normally 
distributed. To obtain data with normal distribution and to include it in the analysis of the 
difference in complexity in resting state EEG data, normalized values of SampEn and HFD 
obtained from epochs of recorded EEG were calculated as log10 normalization in SPSS. 
Normalized SampEn and HFD data were compared using ANOVA with factors state (Controls 
vs. Depression, and Controls vs. Episode vs. Remissions) and position of the electrode (1 to 19). 
For every electrode, ANOVA was repeated for each measure independently. Bonferroni 
correction was used where appropriate. For all analyses, probability values p = 0.05 were 
considered as statistically significant. 
Principal Component analysis (PCA) 
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To reduce the dimensionality of the problem and decorrelate the measures (HFD and 
SampEn calculated from the same epochs extracted from the raw EEG signal), we utilized PCA 
[25] in order to obtain three principal components (PCs) corresponding to largest eigenvalues of 
the sample covariance matrix. We defined percentage of the explained variance by first three 
PCs as ratio between sums of variances of three PCs and original variables. Here we wanted to 
demonstrate the possibility of classification of previously calculated nonlinear measures, by 
utilizing only the first three components in order to see whether the data were separable. We 
used Matlab 15b for this calculation (MathWorks, Masacushets, USA). 
 
Results 
Spectral power maps 
The first level of analysis was to compare spectral power maps of low alpha (8-10Hz), 
high alpha (10-12Hz), and beta (13-30Hz) bands between healthy controls (C) and patients in a 
different phase of the disease (i.e. episode (E) or remission (R), Figure 1). Spectral power maps 
in low alpha band showed an overall decrease in both E and R groups in posterior regions 
(maximum at C3, C4, Cz, P3, P4, Pz, and T3) when compared to C group. In E and R group 
there was an increase in low alpha spectral power in the right prefrontal region (Fp2) and lateral 
right frontal region (F8) when compared to C group. There was a statistically significant effect of 
group (C, E, R) on low alpha (8-10 Hz) spectral power at following regions: C3 - F(2,40)=8.748 
p=0.021; C4 - F(2,40)=5.168, p=0.04; Cz - F(2,40)=6.381, p=0.03; P3 - F(2,40)=5.748, p=0.021; 
P4 - F(2,40)=4.286, p=0.05; and Pz - F(2,40)=13.939, p<0.001. Spectral power maps in high 
alpha band showed a decrease of high alpha spectral power in right prefrontal (Fp2), left 
temporal (T3), and central (C3, Cz) regions in E and R groups when compared to C group. Also, 
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there was a statistically significant effect of group (C, E, R) on high alpha (10-12Hz) spectral 
power at following regions: Fp2 - F(2,40)=9.211, p<0.01; C3 - F(2,40)=4.096, p=0.05; Cz  -
F(2,40)=10.734, p<0.01; and T3 - F(2,40)=8.633, p=0.012.  
Spectral power maps in beta band showed a decrease of beta (13-30 Hz) spectral power at 
frontal (Fz, Fp1, Fp2, F3, F4, F7, F8), and central-temporal (C3, T3) regions in E and R groups 
when compared to C group. In contrast, there was an increase of beta spectral power in posterior 
regions (P3, P4, Pz, T5, T6, O1, O2) in E and R groups when compared to C group. In the E 
group only there was a frontal (F3 > F4) and temporal-occipital (T5/O1 < T6/O2) asymmetry. 
Significant effect of group (C, E, R) was found at following cortical regions: Fp1 -  
F(2,40)=7.207, p=0.018; Fp2 - F(2,40)=8.107, p<0.01; F3 - F(2,40)=12.342, p<0.01; F4 - 
F(2,40)=18.674, p<0.01; Fz - F(2,40)=7.997, p=0.023; F7 - F(2,40)=4.922, p=0.04; F8 - 
F(2,40)=6.817, p=0.033; P3 - F(2,40)=7.002, p=0.018; P4 - F(2,40)=6.699, p=0.03; Pz - 
F(2,40)=14.361, p<0.01; T5 - F(2,40)=13.207, p<0.01; T6 - F(2,40)=14.338, p<0.01; O1 - 
F(2,40)=16.189, p<0.01; and O2 - F(2,40)=16.917, p<0.01.  
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Figure 1. Spectral power maps are showing the difference between healthy persons (C) and those in 
the episode (E) and remission (R). 
 
Higuchi’s fractal dimension (HFD) and Sample entropy (SampEn) 
Figure 2 summarizes the difference in HFD and SampEn values in all three groups 
averaged across all electrodes. HFD values for healthy controls ranged from 1.0093 to 1.0530 
(mean 1.0290), for patients in the episode from 1.01 to 1.3546 (mean 1.0876), and for those in 
remission from 1.0133 to 1.483 (mean 1.1136). SampEn values for healthy controls were 0.0764 
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to 0.3959 (mean 0.1613), in the episode group 0.2006 to 0.7866 (mean 0.3992) and in remission 
group 0.1983 to 0.861 (mean 0.4777).  
ANOVA showed a significant effect of group on HFD (F(2,2334)=30.831, p<0.01) and 
on SampEn values (F(2,2334)=38.863, p<0.01). The post-hoc test showed that both HFD and 
SampEn values were lowest in the C group, followed by participants in the E group. Participants 
in the R group had the highest HFD and SampEn values (HFDControl<HFDEpisode<HFDRemission, 
p<0.01 for each comparison; SampEnControl<SampEnEpisode<SampEnRemission, p<0.01 for each 
comparison).   
 
Figure 2. Averaged values for HFD (left) and SampEn (right) values averaged across all 19 electrodes, 
for all three groups (C- control, E-episode, and R-remission). Note the difference in scale for HFD and 
SampEn. *** p<0.01. 
 
The next level of analysis was to determine effect of a Group (C, E, R) on HFD and 
SampEn values averaged across Regions of Interest – ROIs (ROI 1: left frontal regions Fp1, F3, 
F7; ROI 2: right frontal regions Fp2, F4, F8; ROI 3: Vertex regions Fz, Cz, Pz; ROI 4: left 
temporal-parietal-central-occipital regions T3, T5, P3, C3, O1; and ROI 5: right temporal-
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parietal-central-occipital regions T4, T6, P4, C4, O3). The data for ROI and group are shown in 
Figure 3. ANOVA showed a significant effect of group on HFD values for the ROI 1: 
F(2,366)=83.021, p<0.01, ROI 2: F(2,366)=85.400, p<0.01, ROI 3: F(2,366)=99.117, p<0.01, 
ROI 4: F(2,612)=78.908, p<0.01, and ROI 5: F(2,612)=94.547, p<0.01. The post-hoc test 
showed for each ROI that HFD is lowest in C group followed by E group while R group had the 
highest HFD values. A significant effect of group on SampEn values (ANOVA) was found for 
the ROI 1: F(2,366)=333.302, p<0.01, ROI 2: F(2,366)=308.381, p<0.01, ROI 3: 
F(2,366)=446.666, p<0.01, ROI 4: F(2,612)=464.020, p<0.01, and ROI 5: F(2,612)=492.307, 
p<0.01. The post-hoc test showed for each ROI that SampEn is lowest in C group followed by E 
group while R group had the highest SampEn values.  
 
Figure 3. The comparison of HFD (left) and SampEn (right) values averaged across each Region of 
Interest (ROI). ROI1 included left frontal electrodes (Fp1, Fp3, F7). ROI2 included right frontal 
electrodes (Fp2, F4, F8). ROI3 included vertex electrodes (Fz, Cz, Pz). ROI4 included left temporal-
parietal-central-occipital regions electrodes (T3, T5, P3, C3, O1) and ROI5 included right temporal-
parietal-central-occipital electrodes (T4, T6, P4, C4, O3). C-control, E-episode, R-remission. Note the 
difference in scale for HFD and SampEn. 
 
The final level of analysis was to determine the possible effect of a group on HFD and 
SampEn values for each electrode. ANOVA showed a significant effect of Group (C, E, R) on 
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HFD values for each electrode (p<0.01). However, post-hoc test showed that significant 
difference between each group was found for electrodes Fp1, Fp2, Fz, P3, P4, T5, T6, and Cz 
(p<0.01). Post-hoc Bonferroni correction showed that for each electrode 
HFDControl<HFDEpisode<HFDRemission, p<0.05 for each comparison. A similar result was found for 
SampEn values. ANOVA showed a significant effect of Group (C, E, R) on SampEn values for 
each electrode (p<0.01). Post-hoc showed that this difference is driven by significantly lower 
SampEn values in C group when compared to E and R group. There was no significant 
difference between E and R group for each electrode. However, the post-hoc test showed that 
significant difference between each group was found for electrodes Fp1, Fp2, F4, F7, Fz, P3, P4, 
O2, T5, T6, Cz, and Pz (p<0.01) and that for each electrode SampEnControl<SampEnEpisode 
<SampEnRemission, p<0.05 for each comparison.  
Two-way ANOVA found a statistically significant effect of factors Group (C, E, R) and 
ROI (frontal left, frontal right, vertex, TCPO left, TCPO right), as well as the interaction (Group 
x ROI) on HFD values (p < .001). The same analysis found a statistically significant effect of 
factors Group (p < .001) and ROI (p < .01) on SampEn values. No significant effect of the 
interaction was found.   
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Figure 4: Results of (ANOVA) comparison of calculated sample entropy for certain electrodes which 
are particularly well discriminative: left, the values of SampEn for position Fp1 (fronto-parietal), and 
right, the values of calculated SampEn for EEG recorded from position T3 (temporal). The significant 
difference between those with depression and controls is particularly pronounced, and the difference 
between Exacerbation and Remission is also significant. 
 
Figure 4 shows a spatial representation of significant differences of values of SampEn 
and HFD according to electrode position, i.e. Fractal and SampEn maps. The results show that 
SampEn is more discriminative regarding the number of electrodes with the statistically 
significant difference between C, E, and R.  
 
Figure 5: The spatial representation of significant differences in HFD and SampEn. In orange, 
electrodes from which SampEn values showed a significant difference in comparison to controls, and 
in green electrodes where HFD had a significant difference. The left panel show the difference between 
the whole group of patients compared to controls. Note that SampEn shows better discrimination than 
HFD. The middle panel shows the comparison of al three groups (C vs. E vs. R). A significant 
difference was found on 12 electrodes for SampEn, and on nine electrodes for HFD. Right panel shows 
the comparison of E and R groups. SampEn values were significantly different on Fp1, Fp2, F7, F3, P3, 
P4, T6, O2, Fz and Cz electrodes. HFD values were significantly different on Fz, Cz, P4, and T6 
electrodes. 
 
Figure 5-A shows that for both measures there is a significant difference between the 
patient and control group for the majority of electrodes. However, SampEn showed to 
discriminate R and E group (Figure 5-C) better. SampEn differed between R and E groups on 
Fp1, Fp2, P3, P4, O2, F7, T6, Fz, Cz electrodes, while HFD was different on Fz, Cz, P4, T6 
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electrodes only. When all three phases are examined (Figure 5-B) SampEn shows a significant 
difference on 12, and HFD on 8, out of 19 electrodes.   
Principal Component Analysis (PCA) 
With only the first three Principal Components (PCs) we want here to illustrate that those 
calculated values are separable. Again, SampEn gave more clear separation of the data when 
compared to HFD (on Figure 6, SampEn results are on the left and HFD on the right picture). In 
this study we did not intend to deal with further classification, although a high accuracy could be 
obtained for several machine learning algorithms. 
 
Figure 6: Principal component analysis was used to show the separability of data. We used only first 
three principal components. Blue diamonds are symbols for those who are diagnosed with depression 
and are in remission; green stars are depressed patients who are in exacerbation and red squares are 
representing control group. Panel left represents how separable are the values of SampEn calculated 
from EEG of subjects from these three groups; panel on the right represents the values of calculated 
Higuchi’s fractal dimension which are obviously less separable data, but still distinctive. 
 
Discussion  
The results show that both Higuchi fractal dimension (HFD) and SampEn nonlinear 
measures of resting state EEG signal discriminate between healthy controls and depressed 
patients, the latter having higher complexity. These differences are widely distributed and 
include frontal, midline (vertex), and temporal-parietal-occipital regions. Furthermore, the 
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complexity differs significantly between episode and remission, being higher in remission than 
in the episode phase of the disease. 
Although this last finding is counterintuitive (it would be expected that the remission 
state is closer to the healthy one in every respect), it might be in line with the observation of 
Willner et al. [26]: "It is evident that antidepressants do not normalize brain activity: mood and 
behavior are restored to normal, but the antidepressant-treated brain is in a different state from 
the non-depressed brain." According to the research on the first-episode depression, such brain is 
initially different from the non-depressed one and the differences are structural [27], as well as 
functional [28,29]. In terms of nonlinear dynamic systems, initial conditions of the depressed 
brain system are different from the non-depressed. Even if the dynamics of information 
processing were the same, these different initial conditions would direct the system to steady 
states distinctive from normal. However, the dynamics is probably also different due to 
compensatory mechanisms. For example, functional neuroimaging revealed reduced integrity of 
the uncinate fasciculus and enhanced functional connectivity of anterior cingulate cortex and 
medial temporal lobe in MDD [30]. The higher severity of depression, the more pronounced this 
negative structure-function relation. The authors suggest that the increased functional 
connectivity is a compensatory mechanism for decreased uncinate fasciculus integrity. Willner et 
al. came to a similar conclusion that decreased hippocampal functioning in depression causes an 
increase in the activity of the ventral “affective” system [26]. It is then easy to suppose that the 
enrichment of fronto-limbic connectivity and reorganization of circuits is accompanied by 
increment in complexity.  
The EEG hallmark of depression is the presence of stable hemispheric asymmetry in the 
alpha spectral band, although the differences in other spectral bands were also demonstrated 
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[31]. Interestingly, de Vinne et al [32] showed that frontal alpha asymmetry cannot be used as 
biomarker. At present, there is no consensus about the direction of change. Our spectral analysis 
shows that the power was decreased in alpha and high-alpha bands in majority of the cortical 
regions, but increased in beta bands in posterior regions in patients. This may point towards the 
presence of hyperactivity in posterior regions (alpha desynchronization) of the right hemisphere, 
which is known to process the negative emotional content [33].  
As said in the Introduction, the results concerning complexity of EEG in depressed 
patients are discrepant. What may account for these opposing findings? One important aspect 
pertains to methodological differences between the studies, related to signal acquisition (number 
of EEG electrodes used, sampling frequency, pre-processing of raw signal, i.e., decomposition 
on bands and filtering), as well as experimental design (probing the emotional content, using 
different stimuli, performing cognitive task, etc.). The eyes-closed condition, unlike the eyes-
open condition, allows measurement of the resting state arousal without the influence of cortical 
processing of the visual input in other bands on the complexity of brain dynamics. Also, it should 
be noted that we did not divide the spectrum of the signal to standard bands, but observed the 
changes in broadband. This is important as it has been shown that signal decomposition like 
Fourier, Wavelet, or cosine transformation can impact the result of a subsequent nonlinear 
analysis yielding erroneous results [34,35]. Other reasons may relate to inherent differences 
between nonlinear algorithms that are based on different theoretical frameworks [36,37]. Our 
results are in line with studies that also used Higuchi’s fractal dimension [11,12], that was shown 
to be more accurate than Katz’s algorithm [12]. The difference in complexity values between 
depressed and healthy subjects in our study were much larger than those reported in Bachman et 
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al. [11]. Another possible source of difference is choosing different values for k in Higuchi’s FD 
algorithm; Bachmann et al. [11] used 50 for their k value.  
The results of Fractal and SampEn maps are in line with previous electrophysiological 
studies demonstrating the presence of stable frontal asymmetry [38,39] in MDD. However, in 
this study the signal was not divided to standard bands, hindering conclusion that current 
findings are directly related to the alpha band asymmetry. The results point to elevated 
complexity in frontal, central and right parieto-temporal regions. This is also in line with earlier 
EEG studies [40], which reported similar topographical changes in distribution.  
It should be noted that we used HFD and SampEn, two nonlinear measures able to detect 
differential aspects of the signal under analysis. While HFD examines the complexity in the time 
domain, SampEn can characterize the irregularity of a signal or its predictability. They both 
showed higher complexity in patients with depression when compared to healthy control 
subjects. The difference was much more pronounced when examined by SampEn suggesting 
increased variability, or “irregularity” or unpredictability of the signal. 
Conclusions 
The idea of EEG-based classification of depression is not entirely novel. Our study 
confirmed that it is possible to quantify the difference between depressed patients and controls 
by employing two complexity measures - HFD and SampEn, on resting state EEG. Furthermore, 
it showed, for the first time, that both measures could detect a statistically significant difference 
between depressed patients who were in episode and remission. Whether these and other non-
linear measures may be used as potential clinical markers of disease stage or of the effectiveness 
of various treatments in MDD remains to be confirmed on larger groups of patients. 
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